Status:
COMPLETED
Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Muhimbili University of Health and Allied Sciences
Conditions:
HIV Infections
Pregnancy Complications
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the oral administration of daily selenium supplements to HIV-1 positive pregnant women: enhances immune status and reduces the HIV-1 viral load at six...
Detailed Description
We are recruiting pregnant women who are infected with HIV and assign them to receive selenium or placebo. All women will be given standard prenatal care, including nevirapine for the prevention of mo...
Eligibility Criteria
Inclusion
- HIV-1 Infected women between 12 and 27 weeks of gestation
Exclusion
- Women with clinical AIDS defined according to WHO Criteria
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
915 Patients enrolled
Trial Details
Trial ID
NCT00197561
Start Date
September 1 2003
End Date
August 1 2006
Last Update
November 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muhimibili University College of Health Scienes
Upanga, Dar Es Salaaam, Tanzania